Zygophyloside D - Compound Card

Zygophyloside D

Select a section from the left sidebar

Zygophyloside D

Structure
Zoomed Structure
  • Family: Plantae - Rubiaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Triterpene Glycoside
Canonical Smiles O[C@H]1O[C@H](O[C@H]2CC[C@]3([C@H](C2(C)C)CC[C@@]2([C@@H]3CC=C3[C@]2(CC[C@@]2([C@H]3[C@@H](C)[C@H](C)CC2)C(=O)O)C(=O)O)C)C)[C@@H]([C@H]([C@@H]1O)O)CS(=O)(=O)O
InChI InChI=1S/C36H56O12S/c1-18-9-14-35(30(40)41)15-16-36(31(42)43)21(25(35)19(18)2)7-8-23-33(5)12-11-24(32(3,4)22(33)10-13-34(23,36)6)47-29-20(17-49(44,45)46)26(37)27(38)28(39)48-29/h7,18-20,22-29,37-39H,8-17H2,1-6H3,(H,40,41)(H,42,43)(H,44,45,46)/t18-,19+,20-,22+,23-,24+,25+,26-,27+,28+,29+,33+,34-,35+,36-/m1/s1
InChIKey JSKUOWHEEYVBPO-GMXPSDJBSA-N
Formula C36H56O12S
HBA 9
HBD 6
MW 712.9
Rotatable Bonds 6
TPSA 208.12
LogP 4.08
Number Rings 6
Number Aromatic Rings 0
Heavy Atom Count 49
Formal Charge 0
Fraction CSP3 0.89
Exact Mass 712.35
Number of Lipinski Rule Violations 2
# Species Family Kingdom NCBI Taxonomy ID
1 Mitragyna stipulosa Rubiaceae Plantae 170033

Showing of synonyms

  • Tapondjou LA, Lontsi D, et al. (2002). Structure-activity relationship of triterpenoids isolated from Mitragyna stipulosa on cytotoxicity.. Archives of pharmacal research,2002, 25(3), 270-274. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CC(CC5)OC6CCCCO6

Level: 1

Mol. Weight: 712.9 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CCCC5

Level: 0

Mol. Weight: 712.9 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 712.9 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-6.06
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-5.7
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
68.43

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.37
Plasma Protein Binding
97.13
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
2.9
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-4.27
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.78
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
4.35
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-131822.14
Rat (Acute)
1.95
Rat (Chronic Oral)
2.73
Fathead Minnow
176.98
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
10663.19
Hydration Free Energy
-2.92
Log(D) at pH=7.4
-0.38
Log(P)
1.27
Log S
-3.25
Log(Vapor Pressure)
-339.53
Melting Point
295.64
pKa Acid
3.76
pKa Basic
6.52

No predicted protein targets found for this compound.

Download SDF